Grace Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Grace Therapeutics, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q4 2023.
  • Grace Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $326.000, a 26.4% decline year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $326 -$117 -26.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $280 -$302 -51.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $78K +$77.5K +16710% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q4 2022 $443 Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $582 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $464 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.